These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 21534260)

  • 21. Narrowing the gap between the number of athletes who dope and the number of athletes who are caught: scientific advances that increase the efficacy of antidoping tests.
    Botrè F; de la Torre X; Donati F; Mazzarino M
    Br J Sports Med; 2014 May; 48(10):833-6. PubMed ID: 24668049
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treating the elite athlete: anti-doping information for the health professional.
    Tandon S; Bowers LD; Fedoruk MN
    Mo Med; 2015; 112(2):122-8. PubMed ID: 25958657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Athlete Biological Passport: How to Personalize Anti-Doping Testing across an Athlete's Career?
    Robinson N; Sottas PE; Schumacher YO
    Med Sport Sci; 2017; 62():107-118. PubMed ID: 28578329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Annual banned-substance review: Analytical approaches in human sports drug testing 2020/2021.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2022 Jan; 14(1):7-30. PubMed ID: 34788500
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2011 Jan; 3(1):1-14. PubMed ID: 21254451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The 41
    Thevis M
    Drug Test Anal; 2023; 15(11-12):1310-1311. PubMed ID: 37933681
    [No Abstract]   [Full Text] [Related]  

  • 27. [Faster, higher, stronger: knowledge about old and new doping substances].
    Pieters T; de Hon O
    Ned Tijdschr Geneeskd; 2013; 157(28):A6450. PubMed ID: 23841931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Running ahead of doping: analytical advances and challenges faced by modern laboratories ahead of Rio 2016.
    Aquino Neto FR; Sarderla VF; Mirotti L; Pizzatti L
    Bioanalysis; 2016 Sep; 8(17):1753-6. PubMed ID: 27491844
    [No Abstract]   [Full Text] [Related]  

  • 29. Detection of peptidic erythropoiesis-stimulating agents in sport.
    Reichel C
    Br J Sports Med; 2014 May; 48(10):842-7. PubMed ID: 24677025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 40
    Thevis M
    Drug Test Anal; 2022 Nov; 14(11-12):1810-1811. PubMed ID: 36347805
    [No Abstract]   [Full Text] [Related]  

  • 31. Challenges and threats to implementing the fight against doping in sport.
    Dvorak J; Saugy M; Pitsiladis YP
    Br J Sports Med; 2014 May; 48(10):807-9. PubMed ID: 24764551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Doping detection in animals: A review of analytical methodologies published from 1990 to 2019.
    Moreira F; Carmo H; Guedes de Pinho P; Bastos ML
    Drug Test Anal; 2021 Mar; 13(3):474-504. PubMed ID: 33440053
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Confiscated black market products and nutritional supplements with non-approved ingredients analyzed in the Cologne Doping Control Laboratory 2009.
    Kohler M; Thomas A; Geyer H; Petrou M; Schänzer W; Thevis M
    Drug Test Anal; 2010; 2(11-12):533-7. PubMed ID: 21204286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Athlete Biological Passport: an integral element of innovative strategies in antidoping.
    Vernec AR
    Br J Sports Med; 2014 May; 48(10):817-9. PubMed ID: 24659508
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Annual banned-substance review: analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H; Schänzer W
    Drug Test Anal; 2013 Jan; 5(1):1-19. PubMed ID: 23229872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The analytical challenges of anti-doping analysis.
    Harrison CR
    Anal Bioanal Chem; 2013 Dec; 405(30):9615-6. PubMed ID: 24043378
    [No Abstract]   [Full Text] [Related]  

  • 38. Biomarker monitoring in sports doping control.
    Pottgiesser T; Schumacher YO
    Bioanalysis; 2012 Jun; 4(10):1245-53. PubMed ID: 22651568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A forensic perspective of the AFL investigation into peptides: an antidoping investigation case study.
    Harcourt PR; Marclay F; Clothier B
    Br J Sports Med; 2014 May; 48(10):810-3. PubMed ID: 24642697
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in equine sports testing.
    Kuuranne T
    Drug Test Anal; 2011 Jan; 3(1):18. PubMed ID: 21254453
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.